Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-17FDA Approved: FUROSEMIDE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original ANDA for furosemide, a generic loop diuretic. The approval covers the generic product for i…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Digital Early Warning System for Acute Lung Injury in Liver Surgery
A ClinicalTrials.gov entry describing a study of a digital early warning system to detect acute lung injury in patients undergoing liver sur…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on Static CT and Artificial Intelligence.
Clinical trial entry describing development of an AI-based decision-support system using static CT for perioperative planning around hepatec…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection [Phase 1, Phase 2]
This clinical trial update describes an investigation into CRISPR-edited HLA donor livers to reduce transplant rejection, with Phase 1 and P…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: SASL Swiss Cirrhosis Cohort
A clinical trial update for the SASL Swiss Cirrhosis Cohort sponsored by University Hospital, Basel, currently recruiting participants with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C [Phase 3]
A Phase 3 clinical trial update in patients with liver cirrhosis and sarcopenia reports improved muscle mass and muscle strength with the tr…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
A clinical trial investigates the impact of nutritional factors on prognosis in liver cirrhosis and the development of predictive models, cu…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C [NA]
Recruitment is ongoing for a study screening patients with hepatic fibrosis or liver cirrhosis, including those due to hepatitis B and hepat…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Exploration of a Novel Prognostic Prediction Model for Liver Cirrhosis
Ongoing clinical trial investigating a novel prognostic prediction model for liver cirrhosis; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Liver Cirrhosis [NA]
The document outlines a recruiting clinical trial evaluating a high-protein plant-dominant diet (HiProPlaDo) in liver cirrhosis, with potent…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin Substitution [NA]
A completed clinical trial evaluating the use of external jugular vein occlusion pressure as a measure of intravascular volume during intrav…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) [Phase 2]
Phase 2 study evaluating two doses of Avenciguat in people with liver cirrhosis and portal hypertension has been terminated, with results po…
-
FDA approval · 2025-06-13FDA Approved: BUMETANIDE — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for bumetanide from Qilu Pharmaceutical Co., Ltd., authorizing the generic product's approval.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly [Phase 2]
A Phase 2 trial evaluating Avenciguat in patients with liver cirrhosis and portal hypertension who had esophageal bleeding or ascites was te…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
A Johns Hopkins University–sponsored international trial evaluating liquid biopsy to detect hepatocellular carcinoma in high-risk patients w…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Chronic Hepatitis B Virus Infection in Zambia
An ongoing clinical trial in Zambia studying chronic hepatitis B virus infection and liver-related conditions (fibrosis, cirrhosis, alcoholi…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Exploring the Mechanisms of Postoperative Delirium in Cirrhotic Patients Through Multi-Omics Integrative Analysis
A clinical trial update describes a multi-omics integrative analysis to explore mechanisms of postoperative delirium in patients with liver …
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
This ClinicalTrials.gov update concerns a study in Zambian patients co-infected with HIV and hepatitis B, investigating liver fibrosis and r…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk [NA]
A clinical trial is evaluating abbreviated MRI using gadoxetic acid versus ultrasonography for surveillance of early-stage hepatocellular ca…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: J-Tip Use for Paracentesis in Adults With Liver Cirrhosis and Ascites [NA]
A Northwestern University trial is evaluating if a needle-free skin anesthetic device improves patient comfort during paracentesis in adults…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients [NA]
A clinical trial evaluating laparoscopic splenectomy with azygoportal disconnection to assess liver reserve function in patients with liver …
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis [NA]
A completed clinical trial evaluating contrast-enhanced ultrasound imaging for diagnosing hepatocellular carcinoma in patients with liver ci…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant [NA]
A ClinicalTrials.gov entry from the University of Pennsylvania describes a study evaluating technology-enabled strategies to promote treatme…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma
This clinical trial evaluates a proteome multimarker panel using multiple reaction monitoring as a surveillance tool for hepatocellular carc…
-
FDA approval · 2025-05-08FDA Approved: FUROSEMIDE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for furosemide by Eugia US LLC under an ANDA, confirming approval of the supplement.